AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 6753887 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral disopyramide phosphate (loading dose 150, 200, or 300 mg followed by 100, 150, or 200 mg every 6 hours based on weight)
Number of subjects: 121
Study 6753887 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 121
Study 6753887 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral disopyramide phosphate
Number of subjects: 121
Study 30407649 — intervention group
Group type: EXPERIMENTAL
Intervention: KAATSU + PFMT
Number of subjects: 41
Study 30407649 — intervention group
Group type: COMPARATOR
Intervention: PFMT
Number of subjects: 41
Study 27987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain fatty acid-binding protein
Number of subjects: 57
Study 27987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-free haemoglobin
Number of subjects: 57
Study 27987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological test scores
Number of subjects: 57
Study 27987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of education
Number of subjects: 57
Study 27987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative cognitive dysfunction
Number of subjects: 57
Study 27987229 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function assessment
Number of subjects: 57
Study 25858261 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (oral, twice daily for 7 days)
Number of subjects: 231
Study 25858261 — intervention group
Group type: COMPARATOR
Intervention: Standard supportive care
Number of subjects: 231
Study 23321947 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterosexual anal intercourse (HAI)
Number of subjects: 980
Study 23321947 — intervention group
Group type: EXPERIMENTAL
Intervention: Casual partners
Number of subjects: 980
Study 23321947 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model
Number of subjects: 980
Study 23321947 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of sex partners (for men)
Number of subjects: 980
Study 21142946 — intervention group
Group type: EXPERIMENTAL
Intervention: Soymilk (500 mL daily for 21 days)
Number of subjects: 42
Study 21142946 — intervention group
Group type: COMPARATOR
Intervention: Control (no soymilk)
Number of subjects: 42
Study 19172254 — intervention group
Group type: EXPERIMENTAL
Intervention: Allicin (180 mg capsule once daily for 14 days)
Number of subjects: 18
Study 19172254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 16728906 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg oral risperidone and 2 mg IM lorazepam
Number of subjects: 30
Study 16728906 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg oral haloperidol and 2 mg IM lorazepam
Number of subjects: 30
Study 16728906 — intervention group
Group type: COMPARATOR
Intervention: oral placebo and 2 mg IM lorazepam
Number of subjects: 30
Study 15584846 — intervention group
Group type: EXPERIMENTAL
Intervention: High contact with lineup administrator
Number of subjects: 0
Study 15584846 — intervention group
Group type: COMPARATOR
Intervention: Low contact with lineup administrator
Number of subjects: 0
Study 11334901 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen alone
Number of subjects: 248
Study 11334901 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral estrogens
Number of subjects: 248
Study 11334901 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal estradiol 17‐beta
Number of subjects: 248
Study 11334901 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestogens
Number of subjects: 248
Study 11334901 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone
Number of subjects: 248
Study 11334901 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 248
Study 11334901 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (Hormone Replacement Therapy)
Number of subjects: 248
Study 9284981 — intervention group
Group type: EXPERIMENTAL
Intervention: house-dust-mite allergen
Number of subjects: 20
Study 9284981 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 8322566 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg methadone
Number of subjects: 40
Study 8322566 — intervention group
Group type: COMPARATOR
Intervention: 5 mg diamorphine
Number of subjects: 40
Study 3540097 — intervention group
Group type: EXPERIMENTAL
Intervention: LeVeen shunt
Number of subjects: 57
Study 3540097 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical therapy
Number of subjects: 57
Study 31657234 — intervention group
Group type: EXPERIMENTAL
Intervention: MGDRx EyeBag®
Number of subjects: 42
Study 31657234 — intervention group
Group type: EXPERIMENTAL
Intervention: OPTASETM Moist Heat Mask
Number of subjects: 42
Study 31657234 — intervention group
Group type: COMPARATOR
Intervention: Warm face cloth
Number of subjects: 42
Study 31657234 — intervention group
Group type: EXPERIMENTAL
Intervention: All three groups (MGDRx EyeBag®, OPTASETM Moist Heat Mask, Warm face cloth)
Number of subjects: 42
Study 31657234 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 42
Study 28140753 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg
Number of subjects: 0
Study 28140753 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets 5.25 mg/kg
Number of subjects: 0
Study 28140753 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28140753 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets (both dosages)
Number of subjects: 0
Study 27473545 — intervention group
Group type: EXPERIMENTAL
Intervention: Potentized estrogen
Number of subjects: 50
Study 27473545 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 26402703 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection of 50 U
Number of subjects: 30
Study 26402703 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection of 100 U
Number of subjects: 30
Study 26402703 — intervention group
Group type: EXPERIMENTAL
Intervention: BoNT‐A injection of 200 U
Number of subjects: 30
Study 22810954 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinic-based recruitment
Number of subjects: 0
Study 22810954 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailings
Number of subjects: 0
Study 22810954 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet and social networking advertising
Number of subjects: 0
Study 22810954 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based recruitment
Number of subjects: 0
Study 22810954 — intervention group
Group type: EXPERIMENTAL
Intervention: Advertising on radio, television
Number of subjects: 0
Study 22810954 — intervention group
Group type: EXPERIMENTAL
Intervention: Distributing brochures
Number of subjects: 0
Study 22810954 — intervention group
Group type: EXPERIMENTAL
Intervention: Word-of-mouth referrals
Number of subjects: 0
Study 20542707 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) applied to bone grafts
Number of subjects: 20
Study 20542707 — intervention group
Group type: COMPARATOR
Intervention: Cancellous bone and marrow grafts without PRP (Control group)
Number of subjects: 20
Study 19928395 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic FM system
Number of subjects: 25
Study 19928395 — intervention group
Group type: COMPARATOR
Intervention: Traditional FM system
Number of subjects: 25
Study 19928395 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic FM system with Autosensitivity
Number of subjects: 25
Study 19928395 — intervention group
Group type: COMPARATOR
Intervention: Traditional FM system with Autosensitivity
Number of subjects: 25
Study 19928395 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of Autosensitivity
Number of subjects: 25
Study 17106700 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTSH stimulation in group A (75 patients)
Number of subjects: 129
Study 17106700 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTSH stimulation in group B (19 patients)
Number of subjects: 129
Study 17106700 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTSH stimulation in group C (35 patients)
Number of subjects: 129
Study 14970982 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 24
Study 14970982 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (alone or in combination with other therapies)
Number of subjects: 24
Study 11694607 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-strength tea (15 g)
Number of subjects: 12
Study 11694607 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated water (270 mg caffeine)
Number of subjects: 12
Study 11694607 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study 11694607 — intervention group
Group type: COMPARATOR
Intervention: Half-strength tea (7.5 g)
Number of subjects: 12
Study 9145339 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical practicum
Number of subjects: 0
Study 10155730 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma exchange
Number of subjects: 30
Study 10155730 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective adsorption
Number of subjects: 30
Study 10155730 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective adsorption followed by i.v. IgG
Number of subjects: 30
Study 10155730 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study 2612235 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CRO)
Number of subjects: 120
Study 2612235 — intervention group
Group type: COMPARATOR
Intervention: Imipenem/cilastatin (I/C)
Number of subjects: 120
Study 856049 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone 0.1% as valerate in an ointment base
Number of subjects: 76
Study 856049 — intervention group
Group type: COMPARATOR
Intervention: Fluocinonide 0.05% in a fatty alcohol propylene glycol (FAPG) base
Number of subjects: 76
Study 31282395 — intervention group
Group type: EXPERIMENTAL
Intervention: Oropharyngeal exercises, posture and cervical region exercises for 12 weeks
Number of subjects: 30
Study 31282395 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise recommended, only posture information)
Number of subjects: 30
Study 31199017 — intervention group
Group type: EXPERIMENTAL
Intervention: Two 2.5 hr sessions of psychoeducation and communication skills-based intervention
Number of subjects: 44
Study 31199017 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 44
Study 27816035 — intervention group
Group type: EXPERIMENTAL
Intervention: Four sessions of smoking cessation counseling plus 12 weeks of bupropion treatment and brief physician advice to quit
Number of subjects: 500
Study 27816035 — intervention group
Group type: COMPARATOR
Intervention: No counseling plus 12 weeks of bupropion treatment and brief physician advice to quit
Number of subjects: 500
Study 25378648 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel 20 mg/m² plus cisplatin 25 mg/m² on Day 1, 8, and 15 (docetaxel plus cisplatin)
Number of subjects: 126
Study 25378648 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel 25 mg/m² on the same schedule (docetaxel)
Number of subjects: 126
Study 25604122 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological measures assessing speed of information processing, memory, and executive functioning
Number of subjects: 1500
Study 25604122 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic and clinical factors (older age, lower education, first language other than English or French, Black or Other ethnicity, presence of psychosis)
Number of subjects: 1500
Study 23572137 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose imatinib (800 mg)
Number of subjects: 109
Study 23572137 — intervention group
Group type: COMPARATOR
Intervention: High-dose imatinib (800 mg) in combination with intermediate-dose cytarabine (200 mg/m2 for 7 days)
Number of subjects: 109
Study 20800340 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasmakinetic enucleation of the prostate (PKEP)
Number of subjects: 204
Study 20800340 — intervention group
Group type: COMPARATOR
Intervention: Standard transurethral resection of the prostate (TURP)
Number of subjects: 204
Study 18773733 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrotactile stimulus
Number of subjects: 0
Study 18773733 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrotactile stimulus in one interval
Number of subjects: 0
Study 18773733 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrotactile stimulus in both intervals
Number of subjects: 0
Study 16616232 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipo-ecraprost (60 microg, administered intravenously on each of 5 days per week for 8 weeks)
Number of subjects: 379
Study 16616232 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 379
Study 12792559 — intervention group
Group type: EXPERIMENTAL
Intervention: Proglumide
Number of subjects: 30
Study 12792559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 11009123 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured training protocol for BSE instruction
Number of subjects: 41
Study 9212553 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse coach intervention
Number of subjects: 92
Study 9212553 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse coach plus train parent and child intervention
Number of subjects: 92
Study 9212553 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care condition
Number of subjects: 92
Study 7962654 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional dose cyclosporin plus nifedipine
Number of subjects: 3
Study 7962654 — intervention group
Group type: COMPARATOR
Intervention: Conventional dose cyclosporin
Number of subjects: 3
Study 7962654 — intervention group
Group type: COMPARATOR
Intervention: Low dose cyclosporin plus azathioprine
Number of subjects: 3
Study 3296733 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg i.v. bolus, then 20 mg/h by infusion for 4 h (low-dose continuous infusion metoclopramide)
Number of subjects: 16
Study 3296733 — intervention group
Group type: COMPARATOR
Intervention: 2 mg/kg i.v. bolus every 2 h for three doses (high-dose bolus metoclopramide)
Number of subjects: 16
Study 29020355 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 or 25 mg once daily
Number of subjects: 7020
Study 29020355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study 27898732 — intervention group
Group type: EXPERIMENTAL
Intervention: Male circumcision
Number of subjects: 0
Study 27898732 — intervention group
Group type: COMPARATOR
Intervention: HIV acquisition
Number of subjects: 0
Study 24423999 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive forcing strategies (CFS) training
Number of subjects: 191
Study 24423999 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 191
Study 23870807 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 30
Study 23870807 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 30
Study 20594207 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural Ecosystems Therapy (SET)
Number of subjects: 143
Study 20594207 — intervention group
Group type: COMPARATOR
Intervention: Community Control (CC)
Number of subjects: 143
Study 20594207 — intervention group
Group type: COMPARATOR
Intervention: Person-Centered Approach (PCA)
Number of subjects: 143
Study 19064521 — intervention group
Group type: EXPERIMENTAL
Intervention: B vitamin supplementation (2.5 mg folic acid/d, 50 mg vitamin B‐6/d, and 1 mg vitamin B‐12/d)
Number of subjects: 2009
Study 19064521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2009
Study 16880571 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% metronidazole gel
Number of subjects: 56
Study 16880571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 12657163 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention including educational outreach visits, audit and feedback, and computerized reminders.
Number of subjects: 150
Study 12657163 — intervention group
Group type: COMPARATOR
Intervention: Control group (passive dissemination of guidelines).
Number of subjects: 150
Study 10840412 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete androgen blockade
Number of subjects: 27
Study 8645503 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg eugenol for 7 days
Number of subjects: 10
Study 8645503 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 10
Study 7515704 — intervention group
Group type: EXPERIMENTAL
Intervention: Kaolin-based activated coagulation time (AKT)
Number of subjects: 20
Study 7515704 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose thrombin time (HITT)
Number of subjects: 20
Study 7515704 — intervention group
Group type: COMPARATOR
Intervention: Celite-based activated coagulation time (ACT)
Number of subjects: 20
Study 3606928 — intervention group
Group type: EXPERIMENTAL
Intervention: 6400 units ORG 10172
Number of subjects: 83
Study 3606928 — intervention group
Group type: COMPARATOR
Intervention: 5000 units heparin
Number of subjects: 83
Study 3606928 — intervention group
Group type: EXPERIMENTAL
Intervention: ORG 10172
Number of subjects: 83
Study 31977509 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous Laser Ablation (EVLA)
Number of subjects: 150
Study 31977509 — intervention group
Group type: COMPARATOR
Intervention: Mechanochemical Ablation (MOCA)
Number of subjects: 150
Study 31991063 — intervention group
Group type: EXPERIMENTAL
Intervention: Decongesting therapy guided by ultrasound assessment of the IVC in addition to clinical assessment
Number of subjects: 388
Study 31991063 — intervention group
Group type: COMPARATOR
Intervention: Clinical assessment alone
Number of subjects: 388
Study 29331711 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 supplements (638mg DHA and 772mg EPA per day)
Number of subjects: 194
Study 29331711 — intervention group
Group type: COMPARATOR
Intervention: Copra oil (placebo)
Number of subjects: 194
Study 27474214 — intervention group
Group type: EXPERIMENTAL
Intervention: POWeR+Face-to-face (POWeR+F); up to seven nurse contacts over 6 months
Number of subjects: 818
Study 27474214 — intervention group
Group type: EXPERIMENTAL
Intervention: POWeR+Remote (POWeR+R); up to five emails or brief phone calls over 6 months
Number of subjects: 818
Study 27474214 — intervention group
Group type: COMPARATOR
Intervention: Control group; evidence-based dietetic advice with 6 monthly nurse follow-up
Number of subjects: 818
Study 24717368 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of 12 oz (355 mL)/d SSB (equivalent to 1 can of soda per day)
Number of subjects: 144
Study 24717368 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction of 12 oz/d SSB (equivalent to 1 can of soda per day) after adjusting for confounders
Number of subjects: 144
Study 23008102 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-alpha hydroxyprogesterone caproate (17-OHPC)
Number of subjects: 282
Study 23008102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 282
Study 23008102 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall group
Number of subjects: 282
Study 20870863 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) applied to the motor and prefrontal cortices, 8 sessions over 2.5 weeks.
Number of subjects: 25
Study 20870863 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 25
Study 18464224 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (CS)
Number of subjects: 0
Study 18464224 — intervention group
Group type: COMPARATOR
Intervention: Inhaled corticosteroid and long acting‐b‐agonists (LABA) combination therapy
Number of subjects: 0
Study 18464224 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term combined therapy with inhaled corticosteroid and LABA
Number of subjects: 0
Study 18464224 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroids (CS) in COPD
Number of subjects: 0
Study 18464224 — intervention group
Group type: COMPARATOR
Intervention: Combination inhalers (LABA and CS)
Number of subjects: 0
Study 17059771 — intervention group
Group type: EXPERIMENTAL
Intervention: HES (6% hydroxyethyl starch)
Number of subjects: 60
Study 17059771 — intervention group
Group type: EXPERIMENTAL
Intervention: GEL (4% succinylated gelatin)
Number of subjects: 60
Study 17059771 — intervention group
Group type: COMPARATOR
Intervention: RL (lactated Ringer's solution)
Number of subjects: 60
Study 14583311 — intervention group
Group type: EXPERIMENTAL
Intervention: milrinone
Number of subjects: 30
Study 14583311 — intervention group
Group type: COMPARATOR
Intervention: placebo (control)
Number of subjects: 30
Study 11013194 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite implant
Number of subjects: 34
Study 11013194 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrylic implant
Number of subjects: 34
Study 11013194 — intervention group
Group type: COMPARATOR
Intervention: Healthy control eyes
Number of subjects: 34
Study 8841214 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocervical 0.5 mg of PGE2 gel
Number of subjects: 118
Study 8841214 — intervention group
Group type: COMPARATOR
Intervention: Immediate oxytocin induction of labor
Number of subjects: 118
Study 1517923 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (IVIG) therapy (500 mg/kg)
Number of subjects: 753
Study 1517923 — intervention group
Group type: COMPARATOR
Intervention: Albumin treatment (5 mg/kg)
Number of subjects: 753
Study 1517923 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival rate
Number of subjects: 753
Study 6406435 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion 300 mg/day
Number of subjects: 30
Study 6406435 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion 450 mg/day
Number of subjects: 30
Study 6406435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30700116 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-TXA (three-hour two-dose regimen)
Number of subjects: 229
Study 30700116 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-TXA (11-hour four-dose regimen)
Number of subjects: 229
Study 30700116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study 30700116 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of short-TXA vs long-TXA
Number of subjects: 229